After a conversation with Sanjay this morning I can say with confidence that this is not for research labs. This is DNA for diagnostics or biopharma applications that would be available to everyone through their doctor when approved by the FDA. He said that plasmid is the industry standard and that linear DNA from PCR could displace the entire need for plasmid. I don't pretend to understand the science, but it sure sounded like APDN's linear dna could be the dna component to every dna vaccine out there now or planned.
No wonder Doc Hayward put out this PR before earnings. Just look at crazy biopharma valuations if you want to fantasize a little.
News 
Market Data 
Discover 
AI
